Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben Ben-David

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Urologic Oncology|March 24, 2026
Therapeutic efficacy of Gemcitabine/Docetaxel maintenance in patients with non-muscle-invasive bladder cancer receiving initial Bacillus Calmette-Guérin inductionKaushik P Kolanukuduru, Reuben Ben-David, Brenda Hug, et al.
European Urology Oncology|March 23, 2024
Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical CystectomyReuben Ben-David, Neeraja Tillu, Shivaram Cumarasamy, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
MRI suspicious lesions in patients under active surveillance: Do systematic biopsies still add value?Ziv Savin, Reuben Ben-David, Avishay Shem-Tov Dlugy, et al.
JCO Precision Oncology|September 30, 2024
Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell CarcinomaReuben Ben-David, Parissa Alerasool, Hitasha Kalola, et al.
European Urology Focus|September 21, 2024
Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non-muscle-invasive Bladder CancerKaushik P Kolanukuduru, Reuben Ben-David, Sarah Lidagoster, et al.
The Prostate|October 5, 2025
Diagnostic Value of Micro-Ultrasound in Identifying Local Recurrence After Radical ProstatectomyBasil Kaufmann, Manish Choudhary, Ashutosh Maheshwari, et al.
BJU International|October 16, 2024
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomesReuben Ben-David, Sarah Lidagoster, Jack Geduldig, et al.
Urologic Oncology|September 14, 2024
The prognostic significance of circulating tumor DNA in patients with positive lymph node disease after robotic-assisted radical cystectomy: A contemporary analysisReuben Ben-David, Sarah Lidagoster, Jack Geduldig, et al.
World Journal of Urology|May 29, 2025
Does having an asymptomatic renal stone increase morbidity after radical cystectomy?Ziv Savin, Reuben Ben-David, Vinay Durbhakula, et al.
World Journal of Urology|April 23, 2024
Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysisReuben Ben-David, Francesco Pellegrino, Parissa Alerasool, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Urologic Oncology|March 24, 2026
Therapeutic efficacy of Gemcitabine/Docetaxel maintenance in patients with non-muscle-invasive bladder cancer receiving initial Bacillus Calmette-Guérin inductionKaushik P Kolanukuduru, Reuben Ben-David, Brenda Hug, et al.
European Urology Oncology|March 23, 2024
Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical CystectomyReuben Ben-David, Neeraja Tillu, Shivaram Cumarasamy, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
MRI suspicious lesions in patients under active surveillance: Do systematic biopsies still add value?Ziv Savin, Reuben Ben-David, Avishay Shem-Tov Dlugy, et al.
JCO Precision Oncology|September 30, 2024
Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell CarcinomaReuben Ben-David, Parissa Alerasool, Hitasha Kalola, et al.
European Urology Focus|September 21, 2024
Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non-muscle-invasive Bladder CancerKaushik P Kolanukuduru, Reuben Ben-David, Sarah Lidagoster, et al.
The Prostate|October 5, 2025
Diagnostic Value of Micro-Ultrasound in Identifying Local Recurrence After Radical ProstatectomyBasil Kaufmann, Manish Choudhary, Ashutosh Maheshwari, et al.
BJU International|October 16, 2024
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomesReuben Ben-David, Sarah Lidagoster, Jack Geduldig, et al.
Urologic Oncology|September 14, 2024
The prognostic significance of circulating tumor DNA in patients with positive lymph node disease after robotic-assisted radical cystectomy: A contemporary analysisReuben Ben-David, Sarah Lidagoster, Jack Geduldig, et al.
World Journal of Urology|May 29, 2025
Does having an asymptomatic renal stone increase morbidity after radical cystectomy?Ziv Savin, Reuben Ben-David, Vinay Durbhakula, et al.
World Journal of Urology|April 23, 2024
Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysisReuben Ben-David, Francesco Pellegrino, Parissa Alerasool, et al.
Pageof 7